Cytek Biosciences (CTKB) Profit After Tax (QoQ) (2020 - 2026)
Cytek Biosciences (CTKB) Profit After Tax (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.56% |
| Mar 31, 2026 | 57.20% |
| Dec 31, 2025 | -854.23% |
| Sep 30, 2025 | 17.27% |
| Jun 30, 2025 | 51.03% |
| Mar 31, 2025 | -204.29% |
| Dec 31, 2024 | 783.83% |
| Sep 30, 2024 | 111.86% |
| Jun 30, 2024 | -69.14% |
| Mar 31, 2024 | -212.10% |
| Dec 31, 2023 | 187.68% |
| Sep 30, 2023 | -43.03% |
| Jun 30, 2023 | 35.54% |
| Mar 31, 2023 | -292.89% |
| Dec 31, 2022 | 306.57% |
| Sep 30, 2022 | 223.65% |
| Jun 30, 2022 | 67.47% |
| Mar 31, 2022 | -548.05% |
| Dec 31, 2021 | -196.24% |
| Sep 30, 2021 | -87.04% |